Aster Capital Management (Difc) LTD Kymera Therapeutics, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $540 Billion
- Q1 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 1,716 shares of KYMR stock, worth $74,011. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,716
Previous 87
1872.41%
Holding current value
$74,011
Previous $3.5 Million
1437.06%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$289 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$279 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$259 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$259 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$226 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.36B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...